Differences

This shows you the differences between two versions of the page.

--- wiki:start:demo [2022/04/09 18:39]
kevinkallmes
+++ wiki:start:demo [2023/06/07 20:22]
jthurnham [Non Small Cell Lung Cancer (NSCLC): Tyrosine kinase inhibitors (TKIs)]
@@ Line 1: / Line 1: @@
 ====== Demo Nests ======
-Want to try out Nested Knowledge, but don't have a research question in mind? Don't want to make an upfront time investment building a nest? No problem, see how both AutoLit and Synthesis work from complete examples! The below links are walkthroughs of demos you may open from your [[https://nested-knowledge.com/gather|AutoLit Home]].
+Want to try out Nested Knowledge, but don't have a research question in mind? Don't want to make an upfront time investment building a nest? No problem, see how both AutoLit and Synthesis work from complete examples!
+{{youtube>NJmXN3FWYx4}}
+The below links are walkthroughs of demos you may open from your [[https://nested-knowledge.com/gather|AutoLit Home]] and clicking "Demo Nests" on the left hand side.
+{{:wiki:start:img190.png?nolink&  }}
+You have the choice of three different demo nests depending on your research project type!
+{{ :undefined:demonestss.png?nolink |}}
 ==== COVID-19: Anti-virals ====
@@ Line 7: / Line 19: @@
   * Our [[:wiki:start:demo:covid19|COVID-19: Antivirals]] nest was [[https://pubmed.ncbi.nlm.nih.gov/35100985/|published]] in BMC Infectious Disease in January 2022. You can use a copy of the nest to practice searching the COVID-19 literature.
-==== Osteoarthritis: Tanezumab ====
+==== Non Small Cell Lung Cancer (NSCLC): Tyrosine kinase inhibitors (TKIs) ====
-  * Our [[:wiki:start:demo:osteoarthritis|Osteoarthritis: Tanezumab]] nest examines the safety and efficacy of different doses of Tanezumab, a therapeutic that recently underwent [[https://www.fda.gov/media/146867/download|FDA scrutiny]] for adverse events in high dose ranges.
+  * Our [[:wiki:start:demo:hta_nsclc|NSCLC: Tyrosine Kinase Inhibitors]] nest examines the treatment of NSCLC with various types of tyrosine kinase inhibitors. This is based on a published [[https://icer.org/assessment/non-small-cell-lung-cancer-2016/ | Institute for Clinical and Economic Review (ICER) review]].
+//This nest is specifically designed to meet the requirements of Health Technology Assessment (HTA) body: [[https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines#:~:text=NICE%20guidelines%20are%20evidence%2Dbased,in%20particular%20circumstances%20or%20settings.|National Institute for Health and Care Excellence (NICE).]]//
 ==== Heart Failure: ACE Inhibitors & ARBs ====
   * Recent advances in ARBs, a new class of drug for heart failure with reduced ejection fraction, inspoired our [[:wiki:start:demo:heart|Heart Failure: ACE Inhibitors & ARBs]] nest. Here, we compare the more conventional drug class (ACE Inhibitors) against ARBs.
-==== Employee Practice Nest ====
-  * Meant for completion by members of the Nested Knowledge team: [[:wiki:practice|Nested Knowledge Employee Practice Nest]].

Nested Knowledge

User Tools

Site Tools

Differences

Page Tools